Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slavomira Doktorovova

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Delivery|February 26, 2009
Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive reviewSlavomira Doktorovova, Eliana B Souto
Pharmaceutical Development and Technology|September 27, 2017
Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell linesSlavomira Doktorovova, Eliana B Souto, Amélia M Silva
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 18, 2014
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro dataSlavomira Doktorovova, Eliana B Souto, Amélia M Silva
Pharmaceutical Development and Technology|July 30, 2019
Key production parameters for the development of solid lipid nanoparticles by high shear homogenizationEliana B Souto, Slavomira Doktorovova, Aleksandra Zielinska, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 26, 2018
Surface-tailored anti-HER2/neu-solid lipid nanoparticles for site-specific targeting MCF-7 and BT-474 breast cancer cellsEliana B Souto, Slavomira Doktorovova, Joana R Campos, et al.
Current Eye Research|July 6, 2010
Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugsEliana B Souto, Slavomira Doktorovova, Elisabet Gonzalez-Mira, et al.
Journal of Applied Toxicology : JAT|November 19, 2013
Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticlesSlavomira Doktorovova, Amélia M Silva, Isabel Gaivão, et al.
The Journal of Physical Chemistry. B|July 14, 2011
Chain-length dependence of insertion, desorption, and translocation of a homologous series of 7-nitrobenz-2-oxa-1,3-diazol-4-yl-labeled aliphatic amines in membranesRenato M S Cardoso, Patricia A T Martins, Filipe Gomes, et al.
Current Cancer Drug Targets|November 12, 2014
Looking out for cancer stem cells' properties: the value-driving role of CD44 for personalized medicinesSara Horta, Ana Lúcia Agostinho, Rita Mateus, et al.
Pharmaceutical Development and Technology|October 9, 2013
Trehalose is not a universal solution for solid lipid nanoparticles freeze-dryingSlavomira Doktorovova, Ranjita Shegokar, Lisete Fernandes, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Delivery|February 26, 2009
Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive reviewSlavomira Doktorovova, Eliana B Souto
Pharmaceutical Development and Technology|September 27, 2017
Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell linesSlavomira Doktorovova, Eliana B Souto, Amélia M Silva
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 18, 2014
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro dataSlavomira Doktorovova, Eliana B Souto, Amélia M Silva
Pharmaceutical Development and Technology|July 30, 2019
Key production parameters for the development of solid lipid nanoparticles by high shear homogenizationEliana B Souto, Slavomira Doktorovova, Aleksandra Zielinska, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 26, 2018
Surface-tailored anti-HER2/neu-solid lipid nanoparticles for site-specific targeting MCF-7 and BT-474 breast cancer cellsEliana B Souto, Slavomira Doktorovova, Joana R Campos, et al.
Current Eye Research|July 6, 2010
Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugsEliana B Souto, Slavomira Doktorovova, Elisabet Gonzalez-Mira, et al.
Journal of Applied Toxicology : JAT|November 19, 2013
Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticlesSlavomira Doktorovova, Amélia M Silva, Isabel Gaivão, et al.
The Journal of Physical Chemistry. B|July 14, 2011
Chain-length dependence of insertion, desorption, and translocation of a homologous series of 7-nitrobenz-2-oxa-1,3-diazol-4-yl-labeled aliphatic amines in membranesRenato M S Cardoso, Patricia A T Martins, Filipe Gomes, et al.
Current Cancer Drug Targets|November 12, 2014
Looking out for cancer stem cells' properties: the value-driving role of CD44 for personalized medicinesSara Horta, Ana Lúcia Agostinho, Rita Mateus, et al.
Pharmaceutical Development and Technology|October 9, 2013
Trehalose is not a universal solution for solid lipid nanoparticles freeze-dryingSlavomira Doktorovova, Ranjita Shegokar, Lisete Fernandes, et al.
Pageof 2